TY - JOUR
T1 - What can you do to… not be influenced?
AU - Dankers, Marloes
AU - Verlegh, Peeter W.J.
AU - Weber, Karla
AU - Nelissen-Vrancken, H. J.M.G.
AU - van Dijk, Liset
AU - Mantel-Teeuwisse, Aukje K.
N1 - Publisher Copyright:
© 2024, Bohn Stafleu van Loghum. All rights reserved.
PY - 2024
Y1 - 2024
N2 - Objectives To identify persuasion strategies in paper-based marketing materials about medicines, sent to general practices. Design Observational study. Method Twenty Dutch general practices collected all mail from pharmaceutical companies during one month. These materials were assessed by researchers with backgrounds in pharmacy and marketing for the presence of seven persuasion strategies, described by Cialdini. The researchers also identified the marketed medicines. Results The general practitioners collected 68 unique marketing materials involving 37 different medicines with a median introduction year of 2012 (range 1966-2022). Factor Xa inhibitors, glucagon-like peptide-1 analogues, and sodium-glucose co-transporter-2 inhibitors were the most marketed drugs. All persuasion strategies described by Cialdini were observed: liking (65% of all materials), authority (29%), social proof (18%), unity (15%), scarcity (13%), reciprocity (12%), and consistency/commitment (3%). Emotional pressure was identified as a new strategy (31%). This strategy leverages the prescriber’s professional responsibility by appealing to the physician's duty to do what is best for the patient. Conclusion General practitioners regularly receive paper-based marketing materials about new medicines that attempt to influence the recipient. In the context of rational use of medicines, it is recommended to be vigilant about such persuasion strategies and to make physicians (both practicing and in training) aware of these strategies, including possible mechanisms to resist them whenever possible.
AB - Objectives To identify persuasion strategies in paper-based marketing materials about medicines, sent to general practices. Design Observational study. Method Twenty Dutch general practices collected all mail from pharmaceutical companies during one month. These materials were assessed by researchers with backgrounds in pharmacy and marketing for the presence of seven persuasion strategies, described by Cialdini. The researchers also identified the marketed medicines. Results The general practitioners collected 68 unique marketing materials involving 37 different medicines with a median introduction year of 2012 (range 1966-2022). Factor Xa inhibitors, glucagon-like peptide-1 analogues, and sodium-glucose co-transporter-2 inhibitors were the most marketed drugs. All persuasion strategies described by Cialdini were observed: liking (65% of all materials), authority (29%), social proof (18%), unity (15%), scarcity (13%), reciprocity (12%), and consistency/commitment (3%). Emotional pressure was identified as a new strategy (31%). This strategy leverages the prescriber’s professional responsibility by appealing to the physician's duty to do what is best for the patient. Conclusion General practitioners regularly receive paper-based marketing materials about new medicines that attempt to influence the recipient. In the context of rational use of medicines, it is recommended to be vigilant about such persuasion strategies and to make physicians (both practicing and in training) aware of these strategies, including possible mechanisms to resist them whenever possible.
UR - http://www.scopus.com/inward/record.url?scp=85192854258&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85192854258&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:85192854258
SN - 0028-2162
VL - 2024
JO - Nederlands Tijdschrift voor Geneeskunde
JF - Nederlands Tijdschrift voor Geneeskunde
IS - 1
M1 - D7997
ER -